Therapeutic Potential of Momordica charantia Against Candida albicans-Induced Hematological Alterations in Albino Mice
Journal of Pharma and Biomedics · 30.03.2026 · 4 (1`) · 353-363
DOI: 10.56810/jpbm.004.01.0161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharma and Biomedics, online erschienen am 30.03.2026. Verfasst von Amna Shehzadi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Candida albicans is an opportunistic fungal pathogen responsible for a range of infections that often lead to marked hematological and physiological disturbances, primarily through oxidative stress, inflammatory responses, and immune imbalance. The present study aimed to investigate the therapeutic potential of Momordica charantia against C. albicans-induced hematological alterations in albino mice. A total of 25 albino mice were randomly allocated into five groups: a normal control group, an infected untreated group, and three treatment groups (T1, T2, and T3) administered graded doses of M. charantia extract following fungal infection. Over a 28 days period, hematological parameters and body weight were regularly assessed to evaluate both efficacy and safety of the treatment. The results revealed that C. albicans infection caused significant disruptions in hematological profiles, including reduced hemoglobin (Hb), red blood cell (RBC) count, and packed cell volume (PCV), along with elevated white blood cell (WBC) and lymphocyte levels. These changes were indicative of infection-induced anemia, systemic inflammation, and immune activation. In addition, alterations in liver and renal biomarkers suggested broader physiological stress in infected animals. Conversely, treatment with M. charantia extract significantly (p < 0.05) improved hematological and biochemical parameters in a dose-dependent manner. Restoration of Hb, RBC, PCV, and platelet indices, along with normalization of WBC counts, highlighted its strong hematoprotective and immunomodulatory effects. Improvements in liver and kidney function further supported its organ-protective potential. Body weight remained stable across all treated groups, indicating good tolerability and absence of toxicity. Overall, M. charantia demonstrated notable therapeutic potential against C. albicans-induced hematological disturbances, likely due to its antioxidant and anti-inflammatory phytoconstituents. Further studies are warranted to isolate its active compounds and elucidate underlying molecular mechanisms.
Zitieren
APA
Shehzadi, A., Ijaz, A., Ashraf, S., Anees, M., Khan, R., Abid, M. S., & Khalid, A. (2026). Therapeutic Potential of Momordica charantia Against Candida albicans-Induced Hematological Alterations in Albino Mice. Journal of Pharma and Biomedics, 4(1`), 353-363. https://doi.org/10.56810/jpbm.004.01.0161
Vancouver
Shehzadi A, Ijaz A, Ashraf S, Anees M, Khan R, Abid MS, et al. Therapeutic Potential of Momordica charantia Against Candida albicans-Induced Hematological Alterations in Albino Mice. Journal of Pharma and Biomedics. 2026;4(1`):353-363. doi:10.56810/jpbm.004.01.0161
BibTeX
@article{Shehzadi2026,
author = {Shehzadi, Amna and Ijaz, Ayesha and Ashraf, Saima and Anees, Muhammad and Khan, Ramsha and Abid, Muhammad Shoban and Khalid, Adeel},
title = {Therapeutic Potential of Momordica charantia Against Candida albicans-Induced Hematological Alterations in Albino Mice},
journal = {Journal of Pharma and Biomedics},
year = {2026},
volume = {4},
number = {1`},
pages = {353--363},
doi = {10.56810/jpbm.004.01.0161}
}
EUVIMED